Entecavir and peginterferon alfa-2a in adults with HBeAg-positive immune tolerant chronic hepatitis B virus infection

Por Feld, Jordan J., Terrault, Norah A., Lin, Hsing-Hua S., Belle, Steven H., Chung, Raymond T., Tsai, Naoky, Khalili, Mandana, Perrillo, Robert, Cooper, Stewart L., Ghany, Marc G., Janssen, Harry L.A., Lok, Anna S.
Publicado no Hepatology (2019)

KIR Genotypic Diversity Can Track Ancestries in Heterogeneous Populations: A Potential Confounder for Disease Association Studies

Por Singh, Komal Manpreet, Phung, Yume T., Kohla, Mohamed S., Lan, Billy Y-A, Chan, Sharon, Suen, Diana L., Murad, Sahar, Rheault, Shana, Davidson, Peter, Evans, Jennifer, Singh, Manpreet, Dohil, Sofie, Osorio, Robert W., Wakil, Adil E., Page, Kimberly, Feng, Sandy, Cooper, Stewart L.
Publicado em 2011

Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir

Por Fong, Tse-Ling, Tien, Andy, Jo, Kahee J., Chu, Danny, Cheung, Eddie, Mena, Edward A., Phan, Quang-Quoc, Yu, Andy S., Mohammed, Wafa, Velasco, Andrew, LeDuc, Vinh-Huy, Nguyen, Nickolas, Han, Steven-Bui, Chang, Mimi, Bae, Ho S., Cho, Yong-Won, Tong, Myron J., Cooper, Stewart L.
Publicado no Dig Dis Sci (2015)

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Por Koh, Christopher, Canini, Laetitia, Dahari, Harel, Zhao, Xiongce, Uprichard, Susan L, Haynes-Williams, Vanessa, Winters, Mark A, Subramanya, Gitanjali, Cooper, Stewart L, Pinto, Peter, Wolff, Erin F, Bishop, Rachel, Han, Ma Ai Thanda, Cotler, Scott J, Kleiner, David E, Keskin, Onur, Idilman, Ramazan, Yurdaydin, Cihan, Glenn, Jeffrey S, Heller, Theo
Publicado no Lancet Infect Dis (2015)